Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial von Laufman, L. R., Spiridonidis, C. H., Pritchard, J., Roach, R., Zangmeister, J., Larrimer, N., Moore, T., Segal, M., Jones, J., Patel, T., Gutterman, L., Carman, L., Colborn, D., Kuebler, J. P.

Volltext

Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial von Spiridonidis, C.H., Laufman, L.R., Carman, L., Moore, T., Blair, S., Jones, J., George, Ch, Patel, T., Roach, R., Rupert, R., Zangmeister, J., Colborn, D., Kuebler, J.Ph

Volltext

Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: A phase II trial of a novel schedule von Spiridonidis, C. H., Laufman, L. R., Jones, J. J., Rhodes, V. A.

Volltext

Combination chemotherapy of the taxanes and antimetabolites: its use and limitations von Smorenburg, C.H, Sparreboom, A, Bontenbal, M, Verweij, J

Volltext

Combination chemotherapy of the taxanes and antimetabolites von Smorenburg, C.H, Sparreboom, A, Bontenbal, M, Verweij, J

Volltext

Uncovering the Molecular Basis for the Better Gefitinib Sensitivity of EGFR with Complex Mutations over Single Rare Mutation: Insights from Molecular Simulations von Li, Miaomiao, Li, Mengrong, Xie, Yanjie, Guo, Jingjing

Volltext

Targeting the EGFR pathway for cancer therapy von Johnston, James B., Navaratnam, Sri, Pitz, Marshall W., Maniate, Jerry M., Wiechec, Emilia, Baust, Heinrich, Gingerich, Joel, Skliris, Georgios P., Murphy, Leigh C., Los, Marek Jan

Volltext

Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study von Todsaporn, Duangjai, Zubenko, Alexander, Kartsev, Victor, Aiebchun, Thitinan, Mahalapbutr, Panupong, Petrou, Anthi, Geronikaki, Athina, Divaeva, Liudmila, Chekrisheva, Victoria, Yildiz, Ilkay, Choowongkomon, Kiattawee, Rungrotmongkol, Thanyada

Volltext

Insect Outbreak and Long-Term Post-Fire Effects on Soil Erosion in Mediterranean Suburban Forest von Kastridis, Aristeidis, Stathis, Dimitrios, Sapountzis, Marios, Theodosiou, Georgios

Volltext

Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analy... von van de Stadt, Eveline Annette, Yaqub, Maqsood, Schuit, Robert C., Bartelink, Imke H., Leeuwerik, Anke F., Schwarte, Lothar A., de Langen, Adrianus J., Hendrikse, Harry, Bahce, Idris

Volltext

Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy von Oizumi, Satoshi, Yamazaki, Koichi, Yokouchi, Hiroshi, Konishi, Jun, Hommura, Fumihiro, Kojima, Tetsuya, Isobe, Hiroshi, Nishimura, Masaharu

Volltext

Clinical Outcomes of Chemotherapeutic Molecules as Single and Multiple Agents in Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Patients von Kwan, Ting Yoon, Chowdhury, Ezharul Hoque

Volltext

International Strategy for Sustainable Growth in Multinational Pharmaceutical Companies von Teramae, Fumio, Makino, Tomohiro, Lim, Yeongjoo, Sengoku, Shintaro, Kodama, Kota

Volltext

Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies von Rajurkar, Swapnil, Mambetsariev, Isa, Pharaon, Rebecca, Leach, Benjamin, Tan, TingTing, Kulkarni, Prakash, Salgia, Ravi

Volltext

Intensification treatment based on early FDG‐PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trial von Pardal, Emilia, Coronado, Mónica, Martín, Alejandro, Grande, Carlos, Marín‐Niebla, Ana, Panizo, Carlos, Bello, José Luis, Conde, Eulogio, Hernández, Miguel T., Arranz, Reyes, Bargay, Joan, González‐Barca, Eva, Pérez‐Ceballos, Elena, Montes‐Moreno, Santiago, Caballero, María Dolores

Volltext

Untargeted Lipidomics of Non-Small Cell Lung Carcinoma Demonstrates Differentially Abundant Lipid Classes in Cancer vs. Non-Cancer Tissue von Mitchell, Joshua M, Flight, Robert M, Moseley, Hunter N B

Volltext

Deep-Learning-Based Predictive Imaging Biomarker Model for EGFR Mutation Status in Non-Small Cell Lung Cancer from CT Imaging von Mahajan, Abhishek, Kania, Vatsal, Agarwal, Ujjwal, Ashtekar, Renuka, Shukla, Shreya, Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Menon, Nandini, Kaushal, Rajiv Kumar, Rane, Swapnil, Chougule, Anuradha, Vaidya, Suthirth, Kaluva, Krishna, Prabhash, Kumar

Volltext

Primary mediastinal large B‐cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at memorial Sloan Kettering from 1980 to 1999 von Hamlin, Paul A., Portlock, Carol S., Straus, David J., Noy, Ariela, Singer, Andrew, Horwitz, Steven M., OConnor, Owen A., Yahalom, Joachim, Zelenetz, Andrew D., Moskowitz, Craig H.

Volltext

A Novel Active Targeting Preparation, Vinorelbine Tartrate (VLBT) Encapsulated by Folate-Conjugated Bovine Serum Albumin (BSA) Nanoparticles: Preparation, Characterization and in V... von Li, Yong, Zhao, Xiuhua, Zu, Yuangang, Han, Xue, Ge, Yunlong, Wang, Weiguo, Yu, Xinyang

Volltext

EGFR/cell membrane chromatography-online-high performance liquid chromatography/mass spectrometry method for screening EGFR antagonists from Radix Angelicae Pubescentis von Wang, SiCen, Sun, Meng, Zhang, YanMin, Zhang, Jie, He, LangChong

Volltext